Brown-Forman B (BF.B) Lags Q4 Earnings and Revenue Estimates

Brown-Forman B (BF.B) reported adjusted quarterly earnings of $0.31 per share, a 13.89% negative surprise versus the Zacks Consensus Estimate of $0.36, and revenues of $894 million, missing estimates by 8.10%. This compares to earnings of $0.56 per share and revenues of $964 million a year ago. Year-to-date, Brown-Forman B shares have underperformed the S&P 500, declining 12.6% versus a 1.5% gain, and the stock currently holds a Zacks Rank #3 (Hold), suggesting market-average performance in the near term.

Analysis

Brown-Forman B (BF.B) reported a significant miss on its quarterly financial results, with earnings per share of $0.31, falling 13.89% short of the Zacks Consensus Estimate of $0.36 and marking a substantial decrease from $0.56 per share in the prior-year period. Concurrently, revenues for the quarter ended April 2025 were $894 million, an 8.10% miss against the consensus estimate and a decline from $964 million year-over-year. This performance contributed to the stock's 12.6% year-to-date decline, contrasting sharply with the S&P 500's 1.5% gain. Historically, Brown-Forman B has surpassed consensus EPS estimates twice in the last four quarters but has only topped revenue estimates once during the same period, indicating some inconsistency in meeting market expectations. Prior to this release, the earnings estimate revision trend was mixed, and the stock holds a Zacks Rank #3 (Hold), suggesting it is expected to perform in line with the market in the near future. The sustainability of its current price and future trajectory will heavily depend on management's forthcoming commentary and any subsequent revisions to earnings expectations, with current consensus for the next quarter at $0.42 EPS on $965.12 million revenue, and $1.84 EPS on $4.12 billion revenue for the current fiscal year.

Key Decisions for Investors

• Investors should closely scrutinize management's commentary on the earnings call to understand the drivers behind the significant earnings and revenue miss and to gauge the outlook for future performance.
• Given the substantial underperformance relative to estimates and the market year-to-date, along with a Zacks Rank #3 (Hold), maintaining current positions may be prudent, but caution is advised before initiating new long positions pending further clarity on recovery prospects.
• Monitor for any revisions to consensus earnings and revenue estimates for upcoming quarters, as these will be critical indicators of the company's ability to address current challenges and improve its financial trajectory.